Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers
Status:
Completed
Trial end date:
2021-03-25
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, placebo-controlled, pharmacokinetic, pharmacodynamic study.
Subjects will be randomized to TSC or placebo to determine the effect of Trans Sodium
Crocetinate (TSC) on Transcutaneous Oximetry Measurements (tcpO2) following a single
administration of TSC in subjects breathing oxygen (O2).